Cargando…

Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets

Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of immature myeloid cells that exist at very low numbers in healthy subjects but can expand significantly in malignant, infectious, and chronic inflammatory diseases. These cells are characterized as early-MDSCs, monocytic-MDSCs, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bizymi, Nikoleta, Bjelica, Sunčica, Kittang, Astrid Olsnes, Mojsilovic, Slavko, Velegraki, Maria, Pontikoglou, Charalampos, Roussel, Mikael, Ersvær, Elisabeth, Santibañez, Juan Francisco, Lipoldová, Marie, Papadaki, Helen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745940/ https://www.ncbi.nlm.nih.gov/pubmed/31723807 http://dx.doi.org/10.1097/HS9.0000000000000168

Ejemplares similares

Estramustine Phosphate Inhibits TGF-β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production
por: Mojsilovic, Sonja S., et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
por: Bizymi, Nikoleta, et al.
Publicado: (2021)

New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
por: Bizymi, Nikoleta, et al.
Publicado: (2022)

P752: TRANSCRIPTOMIC ANALYSIS OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA (CIN)
por: Bizymi, Nikoleta, et al.
Publicado: (2023)

Altered Monocyte Subsets in Patients with Chronic Idiopathic Neutropenia
por: Bizymi, Nikoleta, et al.
Publicado: (2019)

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
por: Fredly, Hanne, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells (MDSC) in the Umbilical Cord Blood: Biological Significance and Possible Therapeutic Applications
por: Bizymi, Nikoleta, et al.
Publicado: (2022)

The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
por: Ersvaer, Elisabeth, et al.
Publicado: (2010)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
por: Kapor, Suncica, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS
por: Velegraki, Maria, et al.
Publicado: (2022)

Regulation of the mesenchymal stem cell fate by interleukin-17: Implications in osteogenic differentiation
por: Krstić, Jelena, et al.
Publicado: (2021)

The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
por: Mojsilovic, Sonja S., et al.
Publicado: (2021)

The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine—The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional Chemotherapy to Allogeneic Stem Cell Transplantation
por: Reikvam, Håkon, et al.
Publicado: (2013)

Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications
por: Reikvam, Håkon, et al.
Publicado: (2011)

Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression
por: Krstić, Jelena, et al.
Publicado: (2015)

Interleukin-17 and Its Implication in the Regulation of Differentiation and Function of Hematopoietic and Mesenchymal Stem Cells
por: Mojsilović, Slavko, et al.
Publicado: (2015)

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
por: Kittang, Astrid Olsnes, et al.
Publicado: (2015)

The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting
por: Pontikoglou, Charalampos G., et al.
Publicado: (2023)

Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications
por: Matheakakis, Angelos, et al.
Publicado: (2021)

Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients
por: Sand, Kristoffer Evebø, et al.
Publicado: (2013)

The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes
por: Kittang, Astrid Olsnes, et al.
Publicado: (2016)

A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae
por: Førde, Jan-Lukas, et al.
Publicado: (2022)

The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation
por: Trivanović, Drenka, et al.
Publicado: (2016)

High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article
por: Kyritsi, Eleni Magdalini A., et al.
Publicado: (2015)

The Role of Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles (MSC-EVs) in Normal and Abnormal Hematopoiesis and Their Therapeutic Potential
por: Batsali, Aristea K., et al.
Publicado: (2020)

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2019)

Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes
por: Kastrinaki, Maria-Christina, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Myeloid-derived suppressor cells in hematological malignancies: friends or foes
por: Lv, Meng, et al.
Publicado: (2019)

Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
por: Liseth, Knut, et al.
Publicado: (2010)

Editorial: Microenvironment-Derived Stem Cell Plasticity
por: Krstic, Jelena, et al.
Publicado: (2017)

Editorial: Microenvironment-derived stem cell plasticity—volume II
por: Gadjanski, Ivana, et al.
Publicado: (2022)

Circulating Myeloid Regulatory Cells: Promising Biomarkers in B-Cell Lymphomas
por: Ferrant, Juliette, et al.
Publicado: (2021)

P821: LATE ONSET AND/OR LONG LASTING NEUTROPENIA IN CHILDHOOD: CLINICAL AND HEMATOLOGICAL CHARACTERISTICS AND OUTCOMES
por: Kelaidi, C., et al.
Publicado: (2022)

Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic Differentiation
por: Obradović, Hristina, et al.
Publicado: (2016)

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
por: Bhardwaj, Vaishali, et al.
Publicado: (2023)

Bone regeneration: the stem/progenitor cells point of view
por: Deschaseaux, Frédéric, et al.
Publicado: (2010)

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
por: Yu, Shunjie, et al.
Publicado: (2022)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022)

Future Perspectives: Therapeutic Targeting of Notch Signalling May Become a Strategy in Patients Receiving Stem Cell Transplantation for Hematologic Malignancies
por: Ersvaer, Elisabeth, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_68it1s83gl12q7l05mkd440s0k